Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes.

MLA

Turner, Jessica M., et al. “Phosphodiesterase-5 Inhibitors in Pregnancy: Systematic Review and Meta-Analysis of Maternal and Perinatal Safety and Clinical Outcomes.” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 129, no. 11, Oct. 2022, pp. 1817–31. EBSCOhost, https://doi.org/10.1111/1471-0528.17163.

APA

Turner, J. M., Russo, F., Deprest, J., Mol, B. W., & Kumar, S. (2022). Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes. BJOG: An International Journal of Obstetrics & Gynaecology, 129(11), 1817–1831. https://doi.org/10.1111/1471-0528.17163

Chicago

Turner, Jessica M., Francesca Russo, Jan Deprest, Ben W. Mol, and Sailesh Kumar. 2022. “Phosphodiesterase-5 Inhibitors in Pregnancy: Systematic Review and Meta-Analysis of Maternal and Perinatal Safety and Clinical Outcomes.” BJOG: An International Journal of Obstetrics & Gynaecology 129 (11): 1817–31. doi:10.1111/1471-0528.17163.